DaVita HealthCare Partners Inc (DVA)
Return on total capital
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings before interest and tax (EBIT) (ttm) | US$ in thousands | 1,602,784 | 1,469,127 | 1,284,975 | 1,312,399 | 1,339,062 | 1,472,225 | 1,635,315 | 1,693,076 | 1,797,370 | 1,789,626 | 1,752,418 | 1,671,862 | 1,694,636 | 1,775,553 | 1,716,220 | 1,768,186 | 1,643,317 | 1,568,637 | 1,479,339 | 1,455,645 |
| Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 1,056,100 | 1,199,200 | 1,017,440 | 825,470 | 712,326 | 532,672 | 604,784 | 843,771 | 755,508 | 1,149,440 | 1,277,780 | 1,248,110 | 1,383,570 | 1,574,760 | 2,153,920 | 1,947,850 | 2,133,410 | 2,318,580 | 4,049,300 | 3,875,350 |
| Return on total capital | 151.76% | 122.51% | 126.29% | 158.99% | 187.98% | 276.38% | 270.40% | 200.66% | 237.90% | 155.70% | 137.15% | 133.95% | 122.48% | 112.75% | 79.68% | 90.78% | 77.03% | 67.66% | 36.53% | 37.56% |
December 31, 2023 calculation
Return on total capital = EBIT (ttm) ÷ (Long-term debt + Total stockholders’ equity)
= $1,602,784K ÷ ($—K + $1,056,100K)
= 151.76%
DaVita Inc's return on total capital has shown fluctuation over the past eight quarters. The trend indicates a gradual decrease from Q1 2022 to Q3 2023, with a significant drop in Q1 2023, before a slight increase in Q4 2023. Despite the fluctuations, the return on total capital has remained relatively stable, hovering around the 12% to 15% range. This suggests that DaVita Inc has been able to effectively utilize its capital to generate returns for its stakeholders, although there may be room for improvement in maximizing the efficiency of its capital utilization strategies.
Peer comparison
Dec 31, 2023